Placebo-Controlled Study to Evaluate the Safety and Efficacy of OPN-305 in Preventing Delayed Renal Graft Function
Clinical trial NCT01794663 · COMPLETED
Trial details
- NCT number
- NCT01794663
- Sponsor
- Opsona Therapeutics Ltd.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2012-10-01
- Primary completion
- 2016-06-30
- Enrollment
- 252
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.